首页 > 市场调查报告书 > 製药

非专利药

市场调查报告书

商品编码

1941800

品牌非专利市场规模、份额和趋势分析报告：按药物类别、应用、给药途径、分销管道、地区和细分市场预测，2026-2033年

Branded Generics Market Size, Share & Trends Analysis Report By Drug Class, By Application, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033

出版日期: 2026年01月19日 | 出版商:

Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

简介目录图表

品牌非专利市场概况

2025年全球品牌非专利市场规模估计为2,769.8亿美元，预计2033年将达到4,530.5亿美元。

预计从 2026 年到 2033 年，市场将以 6.5% 的复合年增长率成长。新兴经济体的强劲需求继续推动市场形成，在医生意识和零售主导的分销网络的支持下，处方品牌学名药的趋势日益明显。

亚太地区仍然是核心业务区域，製造商在慢性病治疗领域维持现有品牌的产量，同时透过固定剂量组合药物和配方改良选择性地强化产品系列。同时，在已开发市场，品牌非专利在治疗连续性和替代药物管理具有重要临床意义的领域中保持着有限但稳定的市场份额。例如，2024年6月，梯瓦製药推出了诺和诺德旗下Victoza的非专利药，目标市场为糖尿病领域。在市场转向新型GLP-1疗法之前，Victoza的年销售额约为16亿美元。此次上市表明，品牌非专利公司仍在从具有成熟处方基础的专利到期药物中获取剩余价值。

另一方面，竞标采购的扩张、更严格的价格管制以及不断上涨的监管合规成本等因素，正日益制约商业环境。这些因素正逐步缩小非专利药和非品牌非专利之间的价格差距，迫使生产商扩大生产规模、提供更多产品系列选择，并专注于研发更复杂的学名药，以维持盈利。整体而言，市场反映了消费者对信赖品牌的持续需求与商品化结构性压力之间的平衡。

区域市场占有率分析（2025 年和 2033 年）
区域市场概览
市场规模及预测趋势分析（2021-2033）
北美洲
- 我们
- 加拿大
- 墨西哥
欧洲
- 英国
- 德国
- 法国
- 义大利
- 西班牙
- 丹麦
- 挪威
- 瑞典
亚太地区
- 日本
- 中国
- 印度
- 韩国
- 澳洲
- 泰国
拉丁美洲
- 巴西
- 阿根廷
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿拉伯聯合大公国
- 科威特

第九章竞争情势

参与公司概况
企业市场分析
公司分类
策略规划
公司简介/列表
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Cipla Ltd.
- Dr. Reddy's Laboratories Ltd.
- Lupin Ltd.
- Aurobindo Pharma Ltd.
- Torrent Pharmaceuticals Ltd.
- Viatris Inc.
- Sanofi
- Abbott

简介目录图表

Product Code: GVR-4-68039-943-5

Branded Generic Market Summary

The global branded generics market size was estimated at USD 276.98 billion in 2025 and is projected to reach USD 453.05 billion by 2033, growing at a CAGR of 6.5% from 2026 to 2033. The market continues to be shaped by strong demand in emerging economies, where prescription behavior favors named generics supported by physician familiarity and retail-driven distribution.

Asia Pacific remains the operational core, with manufacturers sustaining volumes through established brands in chronic therapies while selectively enhancing portfolios via fixed dose combinations and reformulations. In parallel, developed markets maintain limited but stable relevance for branded generics in segments where continuity of therapy and controlled substitution remain clinically important. For instance, in June 2024, Teva Pharmaceutical Industries Ltd. launched a generic version of Novo Nordisk's Victoza, targeting a diabetes segment that had generated approximately USD 1.6 billion in annual sales prior to market transition toward newer GLP 1 therapies. The launch illustrates how branded generic players continue to capture residual value from off patent molecules with established prescribing bases.

At the same time, the operating environment is becoming more constrained due to expanding tender based procurement, tighter pricing controls, and increasing regulatory compliance costs. These factors are gradually narrowing price differentiation between branded and unbranded generics, compelling manufacturers to focus on scale, portfolio selectivity, and complex generics to sustain profitability. Overall, the market reflects a balance between persistent demand for trusted brands and structural pressure toward commoditization.

Global Branded Generics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global branded generics market report based on drug class, application, route of administration, distribution channel, and region:

Drug Class Outlook (Revenue, USD Million, 2021 - 2033)
Alkylating Agents
Antimetabolites
Hormones
Anti-hypertensive
Lipid Lowering drugs
Anti-depressants
Anti-psychotics
Anti-epileptics
Others
Application Outlook (Revenue, USD Million, 2021 - 2033)
Oncology
Cardiovascular Diseases
Neurological Diseases
Gastrointestinal Diseases
Dermatological diseases
Acute and Chronic Pain
Others
Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)
Topical
Oral
Parenteral
Others
Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy & Others
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
Latin America
- Brazil
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1 Market Segmentation & Scope
1.2 Segment Definitions
- 1.2.1 Drug Class
- 1.2.2 Application
- 1.2.3 Route of Administration
1.3 Estimates and Forecast Timeline
1.4 Research Methodology
1.5 Information Procurement
- 1.5.1 Purchased Database
- 1.5.2 GVR's Internal Database
- 1.5.3 Secondary Sources
- 1.5.4 Primary Research
1.6 Information Analysis
- 1.6.1 Data Analysis Models
1.7 Market Formulation & Data Visualization
1.8 Model Details
- 1.8.1 Commodity Flow Analysis
1.9 List of Secondary Sources
1.10 Objectives

Chapter 2. Executive Summary

2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot

Chapter 3 Branded Generics Market Variables, Trends, & Scope

3.1 Market Lineage Outlook
3.2 Market Dynamics
- 3.2.1 Market Driver Analysis
- 3.2.2 Market Restraint Analysis
3.3 Business Environment Analysis
- 3.3.1 Industry Analysis - Porter's Five Forces Analysis
  - 3.3.1.1 Supplier Power
  - 3.3.1.2 Buyer Power
  - 3.3.1.3 Substitution Threat
  - 3.3.1.4 Threat of New Entrants
  - 3.3.1.5 Competitive Rivalry
- 3.3.2 PESTLE Analysis
- 3.3.3 Pipeline Analysis
- 3.3.4 Patent Expiry Analysis
- 3.3.5 Pricing Analysis

Chapter 4. Branded Generics Market: Drug Class Business Analysis

4.1. Drug Class Market Share, 2025 & 2033
4.2. Drug Class Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2021 to 2033 (USD Million)
4.4. Alkylating Agents
- 4.4.1 Alkylating Agents Market, 2021 - 2033 (USD Million)
4.5. Antimetabolites
- 4.5.1 Antimetabolites Market, 2021 - 2033 (USD Million)
4.6. Hormones
- 4.6.1 Hormones Market, 2021 - 2033 (USD Million)
4.7. Anti-hypertensive
- 4.7.1 Anti-hypertensive Market, 2021 - 2033 (USD Million)
4.8. Lipid Lowering drugs
- 4.8.1 Lipid Lowering drugs Market, 2021 - 2033 (USD Million)
4.9. Anti-depressants
- 4.9.1 Anti-depressants Market, 2021 - 2033 (USD Million)
4.10. Anti-psychotics
- 4.10.1 Anti-psychotics Market, 2021 - 2033 (USD Million)
4.11. Anti-epileptics
- 4.11.1 Anti-epileptics Market, 2021 - 2033 (USD Million)
4.12. Others
- 4.12.1 Others Market, 2021 - 2033 (USD Million)

Chapter 5. Branded Generics Market: Application Business Analysis

5.1. Application Market Share, 2025 & 2033
5.2. Application Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
5.4. Oncology
- 5.4.1 Oncology Market, 2021 - 2033 (USD Million)
5.5. Cardiovascular Diseases
- 5.5.1 Cardiovascular Diseases Market, 2021 - 2033 (USD Million)
5.6. Neurological Diseases
- 5.6.1 Neurological Diseases Market, 2021 - 2033 (USD Million)
5.7. Gastrointestinal Diseases
- 5.7.1 Gastrointestinal Diseases Market, 2021 - 2033 (USD Million)
5.8. Dermatological diseases
- 5.8.1 Dermatological diseases Market, 2021 - 2033 (USD Million)
5.9. Acute and Chronic Pain
- 5.9.1 Acute and Chronic Pain Market, 2021 - 2033 (USD Million)
5.10. Others
- 5.10.1 Others Market, 2021 - 2033 (USD Million)

Chapter 6. Branded Generics Market: Route of Administration Business Analysis

6.1. Route of Administration Market Share, 2025 & 2033
6.2. Route of Administration Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2021 to 2033 (USD Million)
6.4. Oral
- 6.4.1 Oral Market, 2021 - 2033 (USD Million)
6.5. Topical
- 6.5.1 Topical Market, 2021 - 2033 (USD Million)
6.4. Parenteral
- 6.4.1 Parenteral Market, 2021 - 2033 (USD Million)
6.5. Others
- 6.5.1 Others Market, 2021 - 2033 (USD Million)

Chapter 7. Branded Generics Market: Distribution Channel Business Analysis

7.1. Distribution Channel Market Share, 2025 & 2033
7.2. Distribution Channel Segment Dashboard
7.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
7.4. Hospital Pharmacy
- 7.4.1 Hospital Pharmacy Market, 2021 - 2033 (USD Million)
7.5. Retail Pharmacy
- 7.5.1 Retail Pharmacy Market, 2021 - 2033 (USD Million)
7.6. Online Pharmacy & Others
- 7.6.1 Online Pharmacy & Others Market, 2021 - 2033 (USD Million)

Chapter 8. Branded Generics Market: Regional Estimates & Trend Analysis

8.1 Regional Market Share Analysis, 2025 & 2033
8.2 Regional Market Dashboard
8.3 Market Size & Forecasts Trend Analysis, 2021 to 2033:
8.4 North America
- 8.4.1 North America Branded Generics Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
- 8.4.2 U.S.
  - 8.4.2.1 Key Country Dynamics
  - 8.4.2.2 Regulatory Framework
  - 8.4.2.3 Pricing Analysis
  - 8.4.2.4 U.S. Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.3 Canada
  - 8.4.3.1 Key Country Dynamics
  - 8.4.3.2 Regulatory Framework
  - 8.4.3.3 Pricing Analysis
  - 8.4.3.4 Canada Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.4 Mexico
  - 8.4.4.1 Key Country Dynamics
  - 8.4.4.2 Regulatory Framework
  - 8.4.4.3 Pricing Analysis
  - 8.4.4.4 Mexico Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5 Europe
- 8.5.1 Europe Branded Generics Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
- 8.5.2 UK
  - 8.5.2.1 Key Country Dynamics
  - 8.5.2.2 Regulatory Framework
  - 8.5.2.3 Pricing Analysis
  - 8.5.2.4 UK Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.3 Germany
  - 8.5.3.1 Key Country Dynamics
  - 8.5.3.2 Regulatory Framework
  - 8.5.3.3 Pricing Analysis
  - 8.5.3.4 Germany Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.4 France
  - 8.5.4.1 Key Country Dynamics
  - 8.5.4.2 Regulatory Framework
  - 8.5.4.3 Pricing Analysis
  - 8.5.4.4 France Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.5 Italy
  - 8.5.5.1 Key Country Dynamics
  - 8.5.5.2 Regulatory Framework
  - 8.5.5.3 Pricing Analysis
  - 8.5.5.4 Italy Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.6 Spain
  - 8.5.6.1 Key Country Dynamics
  - 8.5.6.2 Regulatory Framework
  - 8.5.6.3 Pricing Analysis
  - 8.5.6.4 Spain Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.7 Denmark
  - 8.5.8.1 Key Country Dynamics
  - 8.5.8.2 Regulatory Framework
  - 8.5.8.3 Pricing Analysis
  - 8.5.8.4 Denmark Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.8 Norway
  - 8.5.8.1 Key Country Dynamics
  - 8.5.8.2 Regulatory Framework
  - 8.5.8.3 Pricing Analysis
  - 8.5.8.4 Norway Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.9 Sweden
  - 8.5.8.1 Key Country Dynamics
  - 8.5.8.2 Regulatory Framework
  - 8.5.8.3 Pricing Analysis
  - 8.5.8.4 Sweden Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6 Asia Pacific
- 8.6.1 Asia Pacific Branded Generics Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
- 8.6.2 Japan
  - 8.6.2.1 Key Country Dynamics
  - 8.6.2.2 Regulatory Framework
  - 8.6.2.3 Pricing Analysis
  - 8.6.2.4 Japan Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6.3 China
  - 8.6.3.1 Key Country Dynamics
  - 8.6.3.2 Regulatory Framework
  - 8.6.3.3 Pricing Analysis
  - 8.6.3.4 China Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6.4 India
  - 8.6.4.1 Key Country Dynamics
  - 8.6.4.2 Regulatory Framework
  - 8.6.4.3 Pricing Analysis
  - 8.6.4.4 India Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6.5 South Korea
  - 8.6.5.1 Key Country Dynamics
  - 8.6.5.2 Regulatory Framework
  - 8.6.5.3 Pricing Analysis
  - 8.6.5.4 South Korea Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6.6 Australia
  - 8.6.6.1 Key Country Dynamics
  - 8.6.6.2 Regulatory Framework
  - 8.6.6.3 Pricing Analysis
  - 8.6.6.4 Australia Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6.7 Thailand
  - 8.6.8.1 Key Country Dynamics
  - 8.6.8.2 Regulatory Framework
  - 8.6.8.3 Pricing Analysis
  - 8.6.8.4 Thailand Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.7 Latin America
- 8.8.1 Latin America Branded Generics Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
- 8.8.2 Brazil
  - 8.8.2.1 Key Country Dynamics
  - 8.8.2.2 Regulatory Framework
  - 8.8.2.3 Pricing Analysis
  - 8.8.2.4 Brazil Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.8.3 Argentina
  - 8.8.3.1 Key Country Dynamics
  - 8.8.3.2 Regulatory Framework
  - 8.8.3.3 Pricing Analysis
  - 8.8.3.4 Argentina Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.8 Middle East & Africa
- 8.8.1 Middle East & Africa Branded Generics Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
- 8.8.2 South Africa
  - 8.8.2.1 Key Country Dynamics
  - 8.8.2.2 Regulatory Framework
  - 8.8.2.3 Pricing Analysis
  - 8.8.2.4 South Africa Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.8.3 Saudi Arabia
  - 8.8.3.1 Key Country Dynamics
  - 8.8.3.2 Regulatory Framework
  - 8.8.3.3 Pricing Analysis
  - 8.8.3.4 Saudi Arabia Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.8.4 UAE
  - 8.8.4.1 Key Country Dynamics
  - 8.8.4.2 Regulatory Framework
  - 8.8.4.3 Pricing Analysis
  - 8.8.4.4 UAE Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.8.5 Kuwait
  - 8.8.5.1 Key Country Dynamics
  - 8.8.5.2 Regulatory Framework
  - 8.8.5.3 Pricing Analysis
  - 8.8.5.4 Kuwait Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

9.1. Participant Overview
9.2. Company Market Position Analysis
9.3. Company Categorization
9.4. Strategy Mapping
9.5. Company Profiles/Listing
- 9.5.1 Sun Pharmaceutical Industries Ltd.
  - 9.5.1.1 Overview
  - 9.5.1.2 Financial Performance
  - 9.5.1.3 Product Benchmarking
  - 9.5.1.4 Strategic Initiatives
- 9.5.2 Teva Pharmaceutical Industries Ltd.
  - 9.5.2.1 Overview
  - 9.5.2.2 Financial Performance
  - 9.5.2.3 Product Benchmarking
  - 9.5.2.4 Strategic Initiatives
- 9.5.3 Cipla Ltd.
  - 9.5.3.1 Overview
  - 9.5.3.2 Financial Performance
  - 9.5.3.3 Product Benchmarking
  - 9.5.3.4 Strategic Initiatives
- 9.5.4 Dr. Reddy's Laboratories Ltd.
  - 9.5.4.1 Overview
  - 9.5.4.2 Financial Performance
  - 9.5.4.3 Product Benchmarking
  - 9.5.4.4 Strategic Initiatives
- 9.5.5 Lupin Ltd.
  - 9.5.5.1 Overview
  - 9.5.5.2 Financial Performance
  - 9.5.5.3 Product Benchmarking
  - 9.5.5.4 Strategic Initiatives
- 9.5.6 Aurobindo Pharma Ltd.
  - 9.5.6.1 Overview
  - 9.5.6.2 Financial Performance
  - 9.5.6.3 Product Benchmarking
  - 9.5.6.4 Strategic Initiatives
- 9.5.7 Torrent Pharmaceuticals Ltd.
  - 9.5.7.1 Overview
  - 9.5.7.2 Financial Performance
  - 9.5.7.3 Product Benchmarking
  - 9.5.7.4 Strategic Initiatives
- 9.5.8 Viatris Inc.
  - 9.5.9.1 Overview
  - 9.5.9.2 Financial Performance
  - 9.5.9.3 Product Benchmarking
  - 9.5.9.4 Strategic Initiatives
- 9.5.9 Sanofi
  - 9.5.7.1 Overview
  - 9.5.7.2 Financial Performance
  - 9.5.7.3 Product Benchmarking
  - 9.5.7.4 Strategic Initiatives
- 9.5.10 Abbott
  - 9.5.8.1 Overview
  - 9.5.8.2 Financial Performance
  - 9.5.8.3 Product Benchmarking
  - 9.5.8.4 Strategic Initiatives

简介目录图表

List of Tables

Table 1 Global Branded Generics Market, By Region, 2021 - 2033 (USD Billion)
Table 2 Global Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 3 Global Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
Table 4 Global Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 5 Global Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 6 North America Branded Generics Market, By Country, 2021 - 2033 (USD Billion)
Table 7 North America Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 8 North America Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
Table 9 North America Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 10 North America Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 11 U.S. Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 12 U.S. Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
Table 13 U.S. Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 14 U.S. Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 15 Canada Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 16 Canada Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
Table 17 Canada Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 18 Canada Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 19 Europe Branded Generics Market, By Country, 2021 - 2033 (USD Billion)
Table 20 Europe Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 21 Europe Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
Table 22 Europe Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 23 Europe Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 24 UK Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 25 UK Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
Table 26 UK Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 27 UK Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 28 Germany Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 29 Germany Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
Table 30 Germany Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 31 Germany Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 32 France Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 33 France Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
Table 34 France Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 35 France Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 36 Italy Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 37 Italy Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
Table 38 Italy Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 39 Italy Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 40 Spain Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 41 Spain Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
Table 42 Spain Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 43 Spain Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 44 Denmark Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 45 Denmark Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
Table 46 Denmark Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 47 Denmark Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 48 Sweden Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 49 Sweden Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
Table 50 Sweden Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 51 Sweden Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 52 Norway Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 53 Norway Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
Table 54 Norway Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 55 Norway Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 56 Asia Pacific Branded Generics Market, By Country, 2021 - 2033 (USD Billion)
Table 57 Asia Pacific Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 58 Asia Pacific Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
Table 59 Asia Pacific Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 60 Asia Pacific Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 61 Japan Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 62 Japan Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
Table 63 Japan Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 64 Japan Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 65 China Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 66 China Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
Table 67 China Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 68 China Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 69 India Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 70 India Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
Table 71 India Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 72 India Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 73 Australia Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 74 Australia Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
Table 75 Australia Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 76 Australia Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 77 South Korea Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 78 South Korea Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
Table 79 South Korea Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 80 South Korea Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 81 Thailand Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 82 Thailand Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
Table 83 Thailand Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 84 Thailand Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 85 Latin America Branded Generics Market, By Country, 2021 - 2033 (USD Billion)
Table 86 Latin America Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 87 Latin America Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
Table 88 Latin America Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 89 Latin America Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 90 Brazil Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 91 Brazil Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
Table 92 Brazil Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 93 Brazil Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 94 Mexico Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 95 Mexico Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
Table 96 Mexico Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 97 Mexico Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 98 Argentina Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 99 Argentina Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
Table 100 Argentina Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 101 Argentina Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 102 Middle East & Africa Branded Generics Market, By Country, 2021 - 2033 (USD Billion)
Table 103 Middle East & Africa Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 104 Middle East & Africa Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
Table 105 Middle East & Africa Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 106 Middle East & Africa Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 107 South Africa Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 108 South Africa Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
Table 109 South Africa Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 110 South Africa Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 111 Saudi Arabia Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 112 Saudi Arabia Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
Table 113 Saudi Arabia Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 114 Saudi Arabia Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 115 UAE Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 116 UAE Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
Table 117 UAE Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 118 UAE Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)
Table 119 Kuwait Branded Generics Market, By Drug Class, 2021 - 2033 (USD Billion)
Table 120 Kuwait Branded Generics Market, By Application, 2021 - 2033 (USD Billion)
Table 121 Kuwait Branded Generics Market, By Route of Administration, 2021 - 2033 (USD Billion)
Table 122 Kuwait Branded Generics Market, By Distribution Channel, 2021 - 2033 (USD Billion)

List of Figures

Fig. 1 Branded generics market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value - chain - based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Commodity Flow Analysis
Fig. 10 Branded generics market snapshot
Fig. 11 Penetration and growth prospect mapping
Fig. 12 Branded generics market driver impact
Fig. 13 ANDA approvals in 2024
Fig. 14 Number of deaths attributed to noncommunicable diseases (in million), in 2024
Fig. 15 Branded generics market restraint impact
Fig. 16 Annual savings from generics in the U.S. (USD billion)
Fig. 17 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
Fig. 18 Porter's Five Forces Analysis
Fig. 19 User Perspective Analysis
Fig. 20 Branded generics market: Drug Class Outlook, Revenue, USD Billion, 2021 - 2033 and key takeaways
Fig. 21 Branded generics market: Drug class movement analysis
Fig. 22 Alkylating agents market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 23 Antimetabolites market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 24 Hormones market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 25 Anti - hypertensive market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 26 Lipid lowering drugs market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 27 Anti - depressants market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 28 Anti - psychotics market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 29 Anti - epileptics generic prescription pattern in India (2020)
Fig. 30 Anti - epileptics market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 31 Others market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 32 Branded generics market: Application Outlook, Revenue, USD Billion, 2021 - 2033and key takeaways
Fig. 33 Branded generics market: Application movement analysis
Fig. 34 Oncology market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 35 Cardiovascular diseases market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 36 Neurological diseases market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 37 Acute & chronic pain market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 38 Gastrointestinal diseases market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 39 Dermatological diseases market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 40 Others market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 41 Branded generics market: Route of Administration Outlook, Revenue, USD Billion, 2021 - 2033and key takeaways
Fig. 42 Branded generics market: Route of administration movement analysis
Fig. 43 Topical market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 44 Oral market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 45 Parenteral market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 46 Others market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 47 Branded Generics market: Distribution Channel Outlook, Revenue, USD Billion, 2021 - 2033 and key takeaways
Fig. 48 Branded Generics Market: Distribution Channel Movement Analysis
Fig. 49 Hospital pharmacy market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 50 Retail pharmacy market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 51 Online pharmacy market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 52 Regional marketplace: Key takeaways
Fig. 53 Regional outlook, 2025 & 2033
Fig. 54 North America SWOT Analysis
Fig. 55 North America. market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 56 U.S. key country dynamics
Fig. 57 U.S. market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 58 Canada key country dynamics
Fig. 59 Canada market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 60 Europe SWOT Analysis
Fig. 61 Europe market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 62 UK key country dynamics
Fig. 63 UK market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 64 Germany key country dynamics
Fig. 65 Germany market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 66 France key country dynamics
Fig. 67 France market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 68 Spain key country dynamics
Fig. 69 Spain market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 70 Italy key country dynamics
Fig. 71 Italy market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 72 Denmark key country dynamics
Fig. 73 Denmark market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 74 Sweden key country dynamics
Fig. 75 Sweden market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 76 Norway key country dynamics
Fig. 77 Norway market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 78 Asia - Pacific SWOT Analysis
Fig. 79 Asia - Pacific market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 80 Japan key country dynamics
Fig. 81 Japan market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 82 China key country dynamics
Fig. 83 China. market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 84 India key country dynamics
Fig. 85 India market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 86 Australia key country dynamics
Fig. 87 Australia market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 88 South Korea key country dynamics
Fig. 89 South Korea market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 90 Thailand key country dynamics
Fig. 91 Thailand market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 92 Latin America SWOT Analysis
Fig. 93 Latin America. market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 94 Brazil key country dynamics
Fig. 95 Brazil market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 96 Mexico key country dynamics
Fig. 97 Mexico market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 98 Argentina key country dynamics
Fig. 99 Argentina market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 100 Middle East & Africa SWOT Analysis
Fig. 101 MEA market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 102 South Africa key country dynamics
Fig. 103 South Africa market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 104 Saudi Arabia key country dynamics
Fig. 105 Saudi Arabia market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 106 UAE key country dynamics
Fig. 107 UAE market estimates and forecast, 2021 - 2033 (USD Billion)
Fig. 108 Kuwait key country dynamics
Fig. 109 Kuwait market estimates and forecast, 2021 - 2033 (USD Billion)

02-2729-4219

+886-2-2729-4219

License/价格

品牌非专利市场规模、份额和趋势分析报告：按药物类别、应用、给药途径、分销管道、地区和细分市场预测，2026-2033年

Branded Generics Market Size, Share & Trends Analysis Report By Drug Class, By Application, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033

品牌非专利市场概况

目录

第一章：调查方法和范围

第二章执行摘要

第三章：品牌非专利市场的变数、趋势与范围

第四章：品牌非专利市场：依药物类别进行业务分析

第五章：品牌非专利市场：按应用领域进行业务分析

第六章：品牌非专利市场：依给药途径进行业务分析

第七章：品牌非专利市场：按分销管道分類的业务分析

第八章：品牌非专利市场：区域估算与趋势分析

第九章竞争情势

Branded Generic Market Summary

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3 Branded Generics Market Variables, Trends, & Scope

Chapter 4. Branded Generics Market: Drug Class Business Analysis

Chapter 5. Branded Generics Market: Application Business Analysis

Chapter 6. Branded Generics Market: Route of Administration Business Analysis

Chapter 7. Branded Generics Market: Distribution Channel Business Analysis

Chapter 8. Branded Generics Market: Regional Estimates & Trend Analysis

Chapter 9. Competitive Landscape

List of Tables

List of Figures

品牌非专利市场规模、份额和趋势分析报告：按药物类别、应用、给药途径、分销管道、地区和细分市场预测，2026-2033年

Branded Generics Market Size, Share & Trends Analysis Report By Drug Class, By Application, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033

品牌非专利市场概况

目录

第一章：调查方法和范围

第二章执行摘要

第三章：品牌非专利市场的变数、趋势与范围

第四章：品牌非专利市场：依药物类别进行业务分析

第五章：品牌非专利市场：按应用领域进行业务分析

第六章：品牌非专利市场：依给药途径进行业务分析

第七章：品牌非专利市场：按分销管道分類的业务分析

第八章：品牌非专利市场：区域估算与趋势分析

第九章 竞争情势

Branded Generic Market Summary

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3 Branded Generics Market Variables, Trends, & Scope

Chapter 4. Branded Generics Market: Drug Class Business Analysis

Chapter 5. Branded Generics Market: Application Business Analysis

Chapter 6. Branded Generics Market: Route of Administration Business Analysis

Chapter 7. Branded Generics Market: Distribution Channel Business Analysis

Chapter 8. Branded Generics Market: Regional Estimates & Trend Analysis

Chapter 9. Competitive Landscape

List of Tables

List of Figures

第九章竞争情势